Purchase Order 75N92023P00014
- Not listed
- The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. government, awarded a $229,104 firm fixed-price purchase order contract to Psomagen Inc., a for-profit organization and manufacturer of goods. The contract, which has no set-aside designation, is for investigating transthyretin (TTR) variants and their impact on sickle cell disease severity using Olink proteomics technology. This contract is part of a larger $500 million single-award Indefinite Delivery...
- <p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Nanoshell Company, LLC, a woman-owned small business. The contract, valued at $148,235.00, is for research into using haptoglobin as a treatment to reduce complications of sickle cell disease. The contract has a firm-fixed price and was awarded on August 1, 2012, with a target completion date of March 15, 2013.</p>
- This is a $32,880.96 firm-fixed-price contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Medical Science & Computing, LLC, a for-profit limited liability company. The contract provides a lab technician to support the maintenance of sample databases for the NHLBI Sickle Cell Branch. This is a Blanket Purchase Agreement (BPA) call order issued under the...
- This contract was awarded by the National Heart, Lung and Blood Institute (NHLBI), a civilian agency of the U.S. government, to Astrix Technology LLC, a for-profit limited liability company. The contract is a delivery order valued at $118,386.85 and has an ultimate completion date of May 23, 2025. The purpose of the contract is to provide staffing for a clinical researcher to expand the research capacity in the lab, which will enable continued research in important areas of gene therapy for...
- This is a Firm Fixed Price BPA Call issued by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract, valued at $133,534.80, is for a Lab Technician to provide support for the maintenance of sample databases, equipment/supply logs, and lab inventory for the NHLBI's Sickle Cell Branch. The contract is not designated as a small business set-aside. The prime contractor is...
- This federal contract award, valued at $76,361.60, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services. The award is a Delivery Order placed under the Multiple Award Schedule (MAS) contract vehicle. The contract was awarded to Government Scientific Source Inc., a for-profit small business organization, to provide a single-cell multiome reagent bundle, single-cell 3' kit V3.1, Chip G kit, Chip J kit, single...
- This is a federal contract award from the National Heart, Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to Astrix Technology LLC, a for-profit limited liability company based in Red Bank, New Jersey. The contract is for a Clinical Research Coordinator to support the recruitment of study participants for the establishment of a repository of bio-specimens comprised of individuals affected with sickle cell disease. The contract is a Firm Fixed...
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services (HHS), to Nanoshell Company, LLC, a woman-owned small business. The contract, valued at $1,292,182, is for the development of a haptoglobin treatment to reduce complications of sickle cell disease. The contract is a definitive, firm-fixed-price contract with a period of performance ending on June...
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services. The prime contractor is STEMCELL TECHNOLOGIES INC, a foreign-owned, for-profit biotechnology company headquartered in Canada, with a registered entity in the United States. The $11,882.50 firm fixed-price contract is a BPA (Blanket Purchase Agreement) call, not a set-aside. It supports the agency's biomedical research mission by...
- This federal contract award, valued at $38,000.00, was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Government Scientific Source Inc. (GSS) to provide a critical instrument for sickle cell research. The contract was issued as a Delivery Order under GSS's existing Multiple Award Schedule (MAS) contract. No set-aside was used for this award. GSS is a leading distributor of laboratory products and equipment, serving...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $100,000 firm-fixed-price purchase order to Functional Fluidics Inc., a minority-owned, for-profit business, to evaluate red blood cell (RBC) health as a biomarker for successful outcomes in hematopoietic stem cell transplantation (HSCT) for sickle cell disease (SCD). This contract, which has no set-aside designation, is a follow-on to previous grants awarded to Functional Fluidics by NHLBI to develop cell adhesion assays and methodologies using microfluidics to study microvascular occlusion associated with SCD. Functional Fluidics' expertise in assessing RBC function aligns with the objective of this contract to identify RBC health as a novel biomarker for monitoring HSCT outcomes in SCD patients.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
RBC Health as a Novel Biomarker of a Successful Outcome in Hematopoietic Stem C | 75N92023Q0540 | Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute | Pre-Solicitation 1/1 | 10/27/22, 8:38 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $100.0k | 11/21/22 |